KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Common Equity (2016 - 2025)

Stereotaxis (STXS) has disclosed Common Equity for 16 consecutive years, with $6.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 42.06% to $6.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.3 million, a 42.06% decrease, with the full-year FY2024 number at $6.1 million, down 62.8% from a year prior.
  • Common Equity was $6.3 million for Q3 2025 at Stereotaxis, up from $1.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $36.5 million in Q2 2021 to a low of $1.5 million in Q2 2025.
  • A 5-year average of $20.5 million and a median of $21.4 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: skyrocketed 61.17% in 2021, then tumbled 87.18% in 2025.
  • Stereotaxis' Common Equity stood at $33.8 million in 2021, then fell by 22.15% to $26.3 million in 2022, then plummeted by 37.97% to $16.3 million in 2023, then plummeted by 62.8% to $6.1 million in 2024, then rose by 3.06% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Common Equity are $6.3 million (Q3 2025), $1.5 million (Q2 2025), and $2.9 million (Q1 2025).